Home Amines 26907-54-0
26907-54-0,MFCD00469688
Catalog No.:AA00C1VI

26907-54-0 | 5-P-Tolyl[1,3,4]thiadiazol-2-ylamine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
in stock  
$40.00   $28.00
- +
1g
95%
in stock  
$108.00   $75.00
- +
5g
≥ 97% (HPLC)
in stock  
$359.00   $251.00
- +
25g
≥ 97% (HPLC)
in stock  
$1,004.00   $703.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00C1VI
Chemical Name:
5-P-Tolyl[1,3,4]thiadiazol-2-ylamine
CAS Number:
26907-54-0
Molecular Formula:
C9H9N3S
Molecular Weight:
191.2529
MDL Number:
MFCD00469688
SMILES:
Cc1ccc(cc1)c1nnc(s1)N
Properties
Computed Properties
 
Complexity:
168  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
13  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
1  
XLogP3:
2  

Upstream Synthesis Route

[1]BioorganicandMedicinalChemistry,2014,vol.22,#21,p.5766-5775

[2]BioorganicandMedicinalChemistry,2008,vol.16,#14,p.6663-6668

[3]EuropeanJournalofMedicinalChemistry,2015,vol.95,p.49-63

[4]EuropeanJournalofMedicinalChemistry,2015,vol.106,p.75-84

[5]MedicinalChemistryResearch,2012,vol.21,#6,p.816-824

[6]BulletinoftheKoreanChemicalSociety,2010,vol.31,#8,p.2345-2350

[7]BulletinoftheKoreanChemicalSociety,2011,vol.32,#3,p.1011-1016

[8]AsianJournalofChemistry,2010,vol.22,#7,p.5289-5296

[9]JournaloftheChineseChemicalSociety,2007,vol.54,#3,p.771-777

[10]JournaloftheChineseChemicalSociety,2010,vol.57,#6,p.1327-1330

[11]BioorganicandMedicinalChemistryLetters,2009,vol.19,#15,p.4292-4295

[12]JournalofChemicalResearch,2011,vol.35,#8,p.442-443

[13]Nucleosides,NucleotidesandNucleicAcids,2011,vol.30,#4,p.280-292

[14]BioorganicandMedicinalChemistry,2012,vol.20,#3,p.1181-1187

[15]OrientalJournalofChemistry,2011,vol.27,#2,p.373-383

[16]BioorganicandMedicinalChemistry,2012,vol.20,#9,p.2789-2795

[17]JournalofChemicalResearch,2012,vol.36,#4,p.218-221

[18]RSCAdvances,2014,vol.4,#99,p.55827-55831

[19]MedicinalChemistryResearch,2015,vol.24,#12,p.4058-4069

[20]OrientalJournalofChemistry,2015,vol.31,#4,p.1873-1885

[21]Pharmazie,2018,vol.73,#3,p.123-127

[22]BioorganicChemistry,2018,vol.81,p.88-92

[1]SyntheticCommunications,2018,vol.48,#3,p.285-290

[1]JournalofHeterocyclicChemistry,2017,vol.54,#3,p.1872-1879

[2]BioorganicandMedicinalChemistryLetters,2011,vol.21,#19,p.5735-5738

[3]MonatsheftefurChemie,2013,vol.144,#5,p.681-686

[4]JournaloftheIndianChemicalSociety,2006,vol.83,#11,p.1165-1170

[5]EuropeanJournalofMedicinalChemistry,2008,vol.43,#1,p.135-141

[6]LiebigsAnnalenderChemie,1994,#10,p.989-992

[7]ChemCatChem,2015,vol.7,#11,p.1655-1658

[8]IndianJournalofChemistry,1970,vol.8,p.509-513

[9]JournalofMedicinalChemistry,1988,vol.31,#5,p.902-906

[10]EuropeanJournalofMedicinalChemistry,2008,vol.43,#9,p.1945-1954

[11]MedicinalChemistryResearch,2008,vol.17,#2-7,p.169-181

[12]JournalofEnzymeInhibitionandMedicinalChemistry,2014,vol.29,#5,p.611-618

[13]JournalofOrganicChemistry,2015,vol.80,#2,p.1018-1024

[14]MedicinalChemistryResearch,2016,vol.25,#6,p.1193-1203

[15]EuropeanJournalofMedicinalChemistry,2016,vol.124,p.237-247

[16]EuropeanJournalofMedicinalChemistry,2017,vol.126,p.15-23

[17]MedicinalChemistryResearch,2017,vol.26,#4,p.819-829

[18]CatalysisLetters,2018,vol.148,#11,p.3486-3491

[1]RSCAdvances,2013,vol.3,#19,p.6813-6816

[1]EuropeanJournalofMedicinalChemistry,2016,vol.122,p.302-318

Downstream Synthesis Route

[1]JournalofHeterocyclicChemistry,2017,vol.54,p.1872-1879

[2]BioorganicandMedicinalChemistryLetters,2011,vol.21,p.5735-5738

[3]MonatsheftefurChemie,2013,vol.144,p.681-686

[4]JournaloftheIndianChemicalSociety,2006,vol.83,p.1165-1170

[5]EuropeanJournalofMedicinalChemistry,2008,vol.43,p.135-141

[6]LiebigsAnnalenderChemie,1994,p.989-992

[7]ChemCatChem,2015,vol.7,p.1655-1658

[8]IndianJournalofChemistry,1970,vol.8,p.509-513

[9]JournalofMedicinalChemistry,1988,vol.31,p.902-906

[10]EuropeanJournalofMedicinalChemistry,2008,vol.43,p.1945-1954

[11]MedicinalChemistryResearch,2008,vol.17,p.169-181

[12]JournalofEnzymeInhibitionandMedicinalChemistry,2014,vol.29,p.611-618

[13]JournalofOrganicChemistry,2015,vol.80,p.1018-1024

[14]MedicinalChemistryResearch,2016,vol.25,p.1193-1203

[15]EuropeanJournalofMedicinalChemistry,2016,vol.124,p.237-247

[16]MedicinalChemistryResearch,2017,vol.26,p.819-829

[17]CatalysisLetters,2018,vol.148,p.3486-3491

[18]JournalofMolecularStructure,2020,vol.1199

[1]JournaloftheIndianChemicalSociety,1975,vol.52,p.1200-1201

[1]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1981,vol.20,p.518-520

[1]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1988,vol.27,p.997-1000

[1]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,1988,vol.27,p.997-1000

Literature

Title: (E)-N-(4-Chloro-benzyl-idene)-5-(4-methyl-phen-yl)-1,3,4-thia-diazol-2-amine.

Journal: Acta crystallographica. Section E, Structure reports online 20110401

Title: 5-(4-Meth-ylphenyl)-1,3,4-thia-diazol-2-amine.

Journal: Acta crystallographica. Section E, Structure reports online 20090501

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:26907-54-0 Molecular Formula|26907-54-0 MDL|26907-54-0 SMILES|26907-54-0 5-P-Tolyl[1,3,4]thiadiazol-2-ylamine |Heterocyclic_Building_Blocks